Accurate manipulation of metabolites in the monolignol biosynthetic pathway is a key step for controlling lignin content, structure, and other wood properties important to the bioenergy and biomaterial industries. A crucial component of this strategy is predicting how single and combinatorial knockdowns of monolignol specific gene transcripts influence the abundance of monolignol proteins, which are the driving mechanisms of monolignol biosynthesis. Computational models have been developed to estimate protein abundances from transcript perturbations of monolignol specific genes. The accuracy of these models, however, is hindered by the inability to capture indirect regulatory influences on other pathway genes. Here, we examine the manifestation of these indirect influences collectively on transgenic transcript and protein abundances, identifying putative indirect regulatory influences that occur when one or more specific monolignol pathway genes are perturbed. We created a computational model using sparse maximum likelihood to estimate the resulting monolignol transcript and protein abundances in transgenic Populus trichocarpa based on desired single or combinatorial knockdowns of specific monolignol genes. Using in-silico simulations of this model and root mean square error, we show that our model more accurately estimates transcript and protein abundances in differentiating xylem tissue when individual and families of monolignol genes were perturbed. This approach provides a useful computational tool for exploring the cascaded impact of single and combinatorial modifications of monolignol specific genes on lignin and other wood properties. Additionally, these results can be used to guide future experiments to elucidate the mechanisms responsible for the indirect influences.
48
In addition to transcriptional regulation, post-transcriptional and post-translational 49 regulatory mechanisms relating to translation or protein degradation can play a critical 50 role in protein abundance [13, 35, 36] . Differences in expression of transcripts and 51 proteins suggesting such regulatory mechanisms have been found for genes encoding cell 52 wall proteins in Arabidopsis thaliana [37, 38] and for genes involved in tobacco xylem cell 53 differentiation [39] . These mechanisms were also proposed to explain the poor 54 correlations between some of the monologinol gene transcripts and proteins in some 55 transgenic P. trichocarpa [4] . Having an accurate representation of the protein 56 abundance profile is important to assess how the metabolic pathway is driven. 57 Developing a computational model that captures the indirect regulatory influences 58 between monolignol genes at both the transcript and protein levels is important for 59 exploring how novel transgenic modifications impact lignin and wood characteristics. 60 In this paper we perform differential abundance analyses on the monolignol gene 61 transcript and protein abundances to further characterize epistatic influences on the 62 expression of the monolignol genes in differentiating xylem tissue of P. trichocarpa. We 63 then used the experimental transcript and protein abundance measurements [4] to 64 develop a model that describes the indirect relationships between the monolignol genes 65 as transcript to transcript, transcript to protein, protein to transcript, and protein to 66 protein influences. We used a sparse maximum likelihood estimator [29] to identify 67 potential key indirect regulatory influences between the monolignol gene transcripts and 68 proteins. Through in-silico simulations, our model more accurately estimates 
Results

83
Data description 84 Wang et al. [4] performed a series of systematic transgenic experiments that knocked 85 down each of the 21 lignin specific genes and their gene families in the model tree P. 86 trichocarpa. The absolute transcript abundances were measured using RNAseq, and the 87 absolute protein abundances were obtained using protein cleavage coupled with isotope 88 dilution mass spectrometry (PC-IDMS) [40] . Multiple independent lines were grown for 89 each transgenic construct. Usually three of those lines were selected to show the effects 90 of a range in the level of the targeted knockdown gene expression, providing an data to the wildtype mean in each batch [4] . Additionally, the PC-IDMS approach for 97 quantifying protein abundance was not able to differentiate between the PtrPAL4 and 98 PtrPAL5 proteins because of the near identity of these proteins [40] . The transcript and 99 protein abundances for PtrPAL4 and PtrPAL5 were combined into one, which we refer 100 to as PtrPAL4/5.
101
Differential abundance analysis 102 To further examine the influence of targeted knockdowns on other non-targeted genes, 103 we performed a differential abundance analysis on both the transcripts and protein data. 104 Fig 1 contains heatmaps showing the results for five of the knockdown experiments: 105 construct i69, which targeted PtrC3H3, PtrC4H1, and PtrC4H2 ( Fig 1A) ; construct i29, 106 which targeted PtrCAld5H1 and PtrCAld5H2 ( Fig 1B) ; construct i35, which targeted 107 PtrCAD1 and PtrCAD2 ( Fig 1C) ; construct i15, which targeted Ptr4CL3 and Ptr4CL5 108 ( Fig 1D) ; and construct i21, which targeted PtrCCoAOMT3 ( Fig 1E) . Heatmaps for the 109 remaining transgenics can be found in Supplemental Figs S1-S4. Each column experiments where we also observed an increase in several of the protein abundances.
142
The increase we observe in the proteins in those two knockdowns could lead to wildtype 143 levels in the PtrCAD1 and PtrCAD2 knockdown experiments because the transcript 144 abundances are significantly decreased. This behavior is seen to a lesser degree in the 145 experimental line that had the largest decrease in the Ptr4CL3 and Ptr4CL5 transcripts 146 and proteins. Additionally, we do not observe this behavior in the Ptr4CL3 and 147
Ptr4CL5 knockdown experiments ( Fig 1D) , suggesting that large knockdowns of the 148 Ptr4CL gene family may trump other regulatory influences.
149
In the Ptr4CL3 and Ptr4CL5 transgenics ( Fig 1D) , we observe significant decreases 150 in abundance of both the transcripts and proteins of PtrCAld5H1 and PtrCAld5H2 and 151 an increase in the PtrCAD2 abundances across multiple transgenic lines. Significant 152 decreases in abundance are also observed in the PtrHCT1, PtrHCT6, and 153 PtrCCoAOMT3 proteins in multiple lines. Similar behavior is seen in the transgenics 154 that individually knocked down Ptr4CL3 ( Fig S4A) and Ptr4CL5 ( Fig S4B) , with 155 significant decreases observed in the PtrHCT1, PtrHCT6, PtrCCoAOMT3, and 156 PtrCAD1 proteins. The PtrHCT1, PtrHCT6, Ptr4CL3, and PtrCAD1 proteins are also 157 significantly decreased in the PtrCCoAOMT3 transgenics ( Fig 1E) . There are multiple 158 transgenics where one line showed significant changes in all or almost all of the 159 monolignol transcripts and proteins, but not in the other lines for the same transgenic 160 such as i35-7 ( Fig 1C) , i15-3 ( Fig 1D) , i19-7 ( Fig S3F) , and a13-6 ( Fig S4B) . This 161 behavior could be due to a nonlinear response to a change in the abundance of one or 162 more of the monolignol transcripts and proteins. Capturing the effect of these indirect regulatory influences is necessary to effectively 170 estimate the resulting protein levels that are responsible for driving monolignol 171 biosynthesis. Further, it is necesarry to capture the indirect effects that affect the 172 transcripts and the indirect effects on the proteins separately. 3)). Using only targeted input abundances (yellow), the other untargeted monolignol transcripts and proteins are predicted (red) (B) In the old model only the one-to-one relationships from a monolignol transcript to its protein were included. In scenario 1, only the targeted monolignol transcripts were used as input abundances (yellow), the untargeted transcripts remained at wildtype levels (gray) and the protein abundances were predicted (red). In scenario 2, all of the monolignol transcript abundances were used as input (yellow) to predict (red) the monolignol protein abundances. 174 We developed a computational model that describes the observed cross-talk or 175 interactions among the monolignol genes by representing each monolignol transcript and 176 protein as a linear combination of the other monolignol transcripts and proteins. This 177 formulation allows us to describe the indirect cross-influences as transcript to transcript 178 and protein to transcript influences to represent influences impacting transcription, and 179 transcript to protein and protein to protein influences to represent the indirect 180 influences affecting the protein abundances. We estimated the weights of the 181 connections that make up these linear combinations using a sparse maximum likelihood 182 algorithm and the mean abundances from the experimental lines (see Methods and S1 183 Text). Using this model, we simulated the response of the untargeted monolignol gene 184 transcripts and proteins based on the desired transcript abundance of a targeted 185 monolignol gene or gene family (Fig 2A) . We compare our model with the model from 186 Wang et al. [4] which assumed that all of the protein abundances were proportional to 187 their transcript levels ( Fig 2B) . We compare our model to two specific scenarios of this 188 old model: scenario 1, where the desired targeted transcript levels are specified and the 189 untargeted transcripts remain at wildtype levels, and scenario 2 where the full 190 transcript profile is specified. We estimate the untargeted monolignol transcript and 191 protein abundances using our model and both scenarios of the old model for single gene 192 and gene family knockdowns corresponding to the transgenic experiments [4] . When 193 exploring novel combinatorial knockdowns, however, where complete transcript profiles 194 are unknown, scenario 2 cannot be simulated. We refer to the transcript of a gene as 195 tGENE and the protein of a gene as pGENE in the following sections. 196 We performed a 10x10-fold cross-validation resulting in 100 training and testing Heatmap of the edge matrix B (Eq 3) solved using a sparse maximum likelihood estimator. Green for positive influence, red for negative influence. Edges are from columns to rows (e.g., the first row shows edges tPAL3 → tPAL1, tCCR2 → tPAL1, tHCT6 → tPAL1, pC3H3 → tPAL1, pCAD2 → tPAL1, pCAld5H2 → tPAL1, and pCCoAOMT3 → tPAL1). There were 295 edges detected out of a possible 1540 (19.16% sparse). (B) The corresponding heatmap for the relationships considered in the old model (t i → p i ).
Computational model
These cross-validation results show that our model performs as well or better than the 214 scenario 1 of the old model. 
223
There were 295 relationships detected out of a possible 1540 (19.16% sparse). The full 224 set of relationships and their weights for our model can be found in Table S1 . For with a targeted knockdown of that gene. Such as when the abundance of pCAD1 is 233 decreased in the PtrCCoAOMT3 (Fig 1E) , Ptr4CL3 ( Fig S4A) , or Ptr4CL5 ( Fig S4B) 234 knockdowns, but the changes in transcript abundance that occur when PtrCAD1 is 235 knocked down ( Fig 1C, Fig S2C) are not observed.
236
To further evaluate how well our model captures these cross-influences affecting the 237 monolignol transcript and protein abundances, we used our model and scenarios 1 and 2 238 of the old model to emulate the five transgenic experiments from our differential 239 abundance analysis. For each of the five targeted experiments, we further described the 240 results from the models for a subset of the untargeted monolignol genes that had a 241 significant change in the abundance of their transcripts, proteins, or both in the 242 differential abundance analysis. PtrC4H2 transcripts. The knockdowns range from ∼65% to ∼10% of wildtype levels for 254 tC3H3 and tC4H1, and ∼110% to ∼25% of wildtype levels for tC4H2. These tC3H3, 255 tC4H1, and tC4H2 abundances were used to emulate these knockdown experiments in 256 our model and scenario 1 of the old model. For scenario 2 of the old model, 257 measurements from all of the monolignol transcripts were used.
258
A slight decrease to ∼80% average wildtype levels was experimentally measured for 259 t4CL5 (Fig 5C) , but an increase up to ∼250% was measured for p4CL5 ( Fig 5D) . Our 260 model captured this behavior, estimating a decrease in t4CL5 to ∼80% of wildtype but 261 an increase in p4CL5 to ∼175% of wildtype levels. Neither scenario of the old model 262 captured the increase in p4CL5, with scenario 2 estimating a small decrease in p4CL5 263 to ∼80% corresponding to the decrease measured in t4CL5.
264
No change from wildtype levels was experimentally measured for tCAld5H2 ( Fig 5E) . 265 For pCAld5H2 a decrease to ∼70% of wildtype levels was experimentally measured 266 ( Fig 5F) . For both tCAld5H2 and pCAld5H2, our model over-estimated a decrease in 267 the abundances to ∼70% of wildtype for tCAld5H2 and ∼45% of wildtype for 268 pCAld5H2. While scenario 2 of the old model did not estimate any change in the 269 abundance of pCAld5H2.
270
For all three lines, the measured abundances for tHCT1 remain around wildtype 271 levels ( Fig 5G) while an increase in pHCT1 is experimentally measured ranging up to 272 ∼180% of wildtype levels ( Fig 5H) . Our model estimated wildtype level abundances for 273 tHCT1, and an increase up to ∼150% of wildtype levels for pHCT1, which are targeted, knocking them down to values seen in experimental constructs ( Fig 6) . From 286 the differential abundance analysis, there were 3 transcripts and 4 proteins of 287 untargeted genes that showed significant changes in abundance in at least one of the 288 experimental lines (Figs 1B, 6A ). From these, we selected the PtrPAL2, PtrC3H3, and 289 PtrHCT6 transcripts and proteins to compare the simulated results from our model 290 with scenarios 1 and 2 of the old model. Fig 6B shows the levels of knockdown, ranging 291 from ∼80% to ∼20% of wildtype levels, for each of the three lines for the PtrCAld5H1 292 and PtrCAld5H2 transcripts. These tCAld5H1 and tCAld5H2 abundances were used to 293 emulate these knockdown experiments in our model and scenario 1 of the old model.
294
For scenario 2 of the old model, measurements from all of the monolignol transcripts 295 were used.
296
Increases up to ∼150% of wildtype levels and ∼200% of wildtype levels were 297 experimentally measured for tPAL2 ( Fig 6C) and pPAL2 ( Fig 6D) respectively. Our 298 model estimated increases in abundance up to ∼140% of wildtype levels for tPAL2 and 299 ∼185% of wildtype levels for pPAL2, which are consistent with the experimentally 300 measured abundances. Scenario 2 of the old model was also consistent with the 301 experimentally measured pPAL2 abundances, estimating an increase up to ∼175% of 302 wildtype levels.
303
Our model estimated wildtype level abundances for tC3H3 which is consistent with 304 the experimentally measured abundances ( Fig 6E) . For pC3H3 an increase up to ∼210% 305 of wildtype levels was experimentally measured (Fig 6) F. Our model was consistent 306 with these results, estimating an increase up to ∼200% of wildtype levels. Scenario 2 of 307 the old model, however, was not consistent with the experimental measurements, and 308 estimated wildtype levels for pC3H3.
309
Our model estimated wildtype level abundances for tHCT6 which is consistent with 310 the experimentally measured abundances ( Fig 6G) . For pHCT6 an increase up to 311 ∼280% of wildtype levels was experimentally measured ( Fig 6H) . Our model was 312 consistent with these results, estimating an increase up to ∼265% of wildtype levels.
313
Scenario 2 of the old model did not capture this increase in pHCT6, estimating wildtype 314 levels for all three lines. 315 Overall, our model captured the increase from wildtype in all three of the proteins, 316 while neither scenario of the old model captured the increase in pC3H3 and pHCT6. (Fig 7) . From the differential abundance analysis, there were 18 transcripts and 324 12 proteins of untargeted genes that showed significant changes in abundance in at least 325 one of the experimental lines ( Figs 1C, 7A) . We selected the Ptr4CL3, PtrC4H1, and 326 PtrCAld5H1 transcripts and proteins to compare the simulated results from our model 327 with scenarios 1 and 2 of the old model. Fig 7B shows t4CL3 was experimentally measured in the range of ∼80% to ∼15% of wildtype 335 levels ( Fig 7C) and p4CL3 was experimentally measured in the range of ∼85% to ∼5% 336 of wildtype levels ( Fig 7D) . Our model estimated a decrease to ∼40% of wildtype levels 337 for t4CL3 and a decrease to ∼50% of wildtype levels for p4CL3 for all three lines, 338 roughly consistent with the experimental measurements, though they do not capture the 339 variation across the three lines. Scenario 2 of the old model estimated abundances of 340 p4CL3 ranging from ∼90% to ∼15% of wildtype which is also consistent with the 341 experimentally measured abundances.
342
For tC4H1 a decrease in abundance was experimentally measured ranging from 343 ∼85% to ∼50% of wildtype levels ( Fig 7E) . A decrease in pC4H1 was experimentally 344 measured ranging from ∼100% to ∼40% of wildtype levels ( Fig 7F) . Our model 345 estimated a decrease to ∼60% of wildtype levels for tC4H1 and a decrease to ∼70% of 346 wildtype levels for pC4H1 for all three lines, roughly consistent with the experimental 347 measurements, though again, they do not capture the variation across the three lines.
348
Scenario 2 of the old model estimated a decrease in the abundances of pC4H1 ranging 349 from ∼80% to ∼50% of wildtype levels which are also consistent with the 350 experimentally measured abundances.
351
A decrease in the abundance tCAld5H1 was experimentally measured ranging from 352 ∼60% to ∼20% of wildtype levels (Fig 7G) , and a decrease in pCAld5H1 was 353 experimentally measured ranging from ∼50% to ∼15% of wildtype levels ( Fig 7H) . Our 354 model estimated a decrease to ∼45% of wildtype levels for tCAld5H1 and a decrease to 355 ∼40% of wildtype levels for pCAld5H1 for all three lines, consistent with the model. The estimates from our model for the transcripts and proteins are very similar 364 across the three experimental lines. This is due to the sparse maximum likelihood 365 algorithm identifying PtrCAD1, which was knocked down similarly for all three lines, as 366 a stronger influence on the other transcripts and proteins than PtrCAD2. lines. For all three of the lines, the transcripts were knocked down to around the same 376 levels, ∼5%-10% of wildtype levels. These t4CL3 and t4CL5 abundances were used to 377 emulate these knockdown experiments in our model and scenario 1 of the old model.
378
For scenario 2 of the old model, measurements from all of the monolignol transcripts 379 were used.
380
A decrease in abundance was experimentally measured in all three lines of tCAld5H2 381 ranging from ∼50% to ∼10% of wildtype levels ( Fig 8C) , and in pCAld5H2 ranging 382 from ∼30% to ∼10% of wildtype levels ( Fig 8D) . Our model estimated a decrease to 383 ∼55% of wildtype levels for both tCAld5H2 and pCAld5H2 for all three lines. The 384 decrease from wildtype in the estimated abundances is consistent with the experimental 385 measurements, though the estimates from our model are not as low as the experimental 386 values. Scenario 2 of the old model estimated a decrease in pCAld5H2 ranging from 387 ∼40% to ∼10% of wildtype levels which is consistent with the experimentally measured 388 abundances.
389
There was a large amount of variation in the experimentally measured tCCoAOMT3 390 abundances across the three lines, ranging from an average of ∼150% of wildtype to 391 ∼45% of wildtype levels ( Fig 8E) . For pCCoAOMT3 a decrease in abundance was 392 measured ranging from ∼55% to ∼10% of wildtype levels (Fig 8F) . Our model 393 estimated wildtype levels for tCCoAOMT3 and a decrease to ∼55% of wildtype levels 394 for pCCoAOMT3, consistent with the experimentally measured pCCoAOMT3. Due to 395 the wide range in the measured transcript abundances, scenario 2 of the old model 396 estimates protein abundances ranging from ∼130% of wildtype to ∼40% of wildtype 397 levels. The estimates from scenario 2 of the old model for line i15-03 are consistent with 398 the experimental measurements from that line, but its estimates from the other two 399 lines, i15-02 and i15-01, are not consistent with the experimental measurements.
400
For two of the experimental lines, i15-02 and i15-01, tHCT1 was experimentally 401 measured to be around wildtype levels. For the third line, i15-03, a decrease to ∼25% of 402 wildtype levels was measured ( Fig 8G) . However, a decrease in abundance was 403 experimentally measured for pHCT1 in all three lines to ∼30% of wildtype levels for lines i15-02 and i15-01 and to ∼10% of wildtype levels for line i15-03 ( Fig 8H) . Our 405 model estimated a slight decrease in tHCT1 to ∼80% of wildtype levels for all three 406 lines, and a decrease in pHCT1 to ∼40% of wildtype levels in all three lines. The 407 estimates for tHCT1 are roughly consistent with the experimental measurements for 408 lines i15-02 and i15-01, but not for i15-03 which was much lower. The estimates for 409 pHCT1 are consistent with the experimentally measured abundances for pHCT1 for all 410 three lines. Because a decrease in tHCT1 abundance was only measured in line i15-03, 411 scenario 2 of the old model estimated a decrease in pHCT1 only for that line, to ∼20% 412 of wildtype levels, consistent with the experimental measurements for that line.
413
However, for the other two lines i15-02 and i15-01, scenario 2 of the old model estimated 414 wildtype levels which are not consistent with the experimentally measured abundances 415 from those two lines. (Fig 9) . The differential abundance analysis identified 3 transcripts and 16 proteins of 425 untargeted monolignol genes that had significant changes in abundance in at least one 426 of the experimental lines (Figs 1E, 9A) . We selected the Ptr4CL3, PtrCAD1, and 427 PtrHCT1 transcripts and proteins to compare the simulated results from our model 428 with scenarios 1 and 2 of the old model. Fig 9B shows the range that tCCoAOMT3 was 429 knocked down over the 3 experimental lines. In the first line, i21-03, tCCoAOMT3 was 430 not knocked down from wildtype. In the other two lines it was knocked down to ∼20% 431 of wildtype levels. These tCCoAOMT3 abundances were used to emulate these 432 knockdown experiments in our model and scenario 1 of the old model. For scenario 2 of 433 the old model, measurements from all of the monolignol transcripts were used.
434
A decrease in abundance was experimentally measured for t4CL3 ranging from 435 wildtype levels to ∼40% of wildtype levels (Fig 9C) . However there is a large amount of 436 variation between replicates, especially for lines i21-06 and i21-08. Our model did not 437 estimate any change from wildtype levels for all three lines. A decrease in p4CL3 was 438 experimentally measured ranging from ∼35% to ∼20% of wildtype levels ( Fig 9D) . Our 439 model only estimated a decrease to ∼75% of wildtype levels and scenario 2 of the old 440 model estimated a decrease ranging from no change from wildtype to ∼50% of wildtype, 441 neither of which are very consistent with the decrease that was experimentally 442 measured.
443
A decrease in abundance was experimentally measured for tCAD1 ranging from 444 wildtype levels to ∼60% of wildtype levels (Fig 9E) . However there is, again, a large 445 amount of variation between replicates, especially for lines i21-06 and i21-08. Our model 446 did not estimate any change from wildtype levels for all three lines. A decrease in 447 pCAD1 was experimentally measured ranging from ∼45% to ∼25% of wildtype levels 448 ( Fig 9F) . For the two lines where tCCoAOMT3 was decreased, i21-06 and i21-08, our 449 model estimated a decrease in pCAD1 to ∼55% of wildtype levels, consistent with the 450 expermental values. For the same lines, scenario 2 of the old model estimated a decrease 451 in pCAD1 ranging from ∼75% to ∼55% of wildtype levels.
452
A decrease in abundance was experimentally measured for tHCT1 ranging from 453 ∼120% to ∼50% of wildtype levels (Fig 9G) . Again, there is a large amount of variation 454 between replicates, especially for lines i21-06 and i21-08. Our model did not estimate 455 any change from wildtype levels for tHCT1 for all three lines. A decrease in pHCT1 was 456 experimentally measured ranging from ∼45% to ∼15% of wildtype levels (Fig 9H) . Our 457 model did not estimate any change from wildtype levels for all three lines, while 458 estimates from scenario 2 of the old model ranged from ∼120% to ∼50% of wildtype 459 levels, neither of which are very consistent with the decrease that was experimentally 460 measured.
461
Overall, neither our model, nor the old model, did a good job at estimating the 462 experimentally observed changes for the Ptr4CL3 and PtrHCT1 transcripts and 463 proteins. However, our model was able to better capture the decrease in pCAD1 than 464 scenario 2 of the old model.
465
Discussion
466
Significant work has been done in recent years to understand the transcriptional 467 regulation of monolignol biosynthesis and wood formation [12, 41, 42] . Chen et al., [12] 468 recently constructed a heirarchical transcriptional regulatory network for wood 469 formation in P. trichocarpa. They identified 7 transcription factors (TFs) that regulated 470 10 of the monolignol specific genes: PtrPAL2, PtrCCoAOMT1, PtrCCoAOMT2, 471 PtrCAld5H1, PtrCAld5H2, PtrAldOMT2, PtrCAD1, PtrHCT1, PtrHCT6, and 472 PtrC4H1 [12] . In the PtrCAD1 and PtrCAD2 transgenics ( Fig 1C) we found these 10 473 transcripts, among others, to be differentially expressed. Many of the TFs that Chen et 474 al., identified as regulators of these genes were also found to be differentially expressed 475 in these transgenics (Fig S5) , further supporting that the cross-influences impacting the 476 abundances of these transcripts are occuring through TF regulation.
477
In addition to changes in transcript abundance, we also observed several cases where 478 monolignol protein abundances were significantly altered when their transcripts were 479 not. This behavior has previously been observed in secondary cell wall proteins of 480 Arabidopsis [37, 38] and in tobacco during cell differentiation [39] . Compared to 481 transcriptional regulation, less is known about the role of post-transcriptional and 482 post-translational regulatory mechanisms on monolignol biosynthesis. Phosphorylation 483 of the PtrPAL protein was proposed for monolignol biosynthesis over two decades ago, 484 though the role of this phosphorylation is unknown [43, 44] . Wang et al., [15] 485 characterized the phosphorylation of the PtrAldOMT2 protein in P. trichocarpa. This 486 post-translational modification was found to impact the activity of the PtrAldOMT2 487 protein but not its abundance. Loziuk et al., identified 12 monolignol proteins that 488 contain motifs for potential glycosylation in P. trichocarpa [16] . The proteins they 489 identified include pPAL1, pPAL3, pPAL4, pPAL5, pC3H3, p4CL3, pCAD2, pCAld5H2, 490 pCCoAOMT1, pCCoAOMT2, pCCR, and pHCT1. Like phosphorylation, glycosylation 491 can regulate protein localization, functional activity, ability to form multienzyme 492 complexes, and stability [16] . 493 Glycosylation could explain some of the behavior we observed in the protein 494 abundance data. In the PtrC3H3, PtrC4H1, and PtrC4H2 knockdowns ( Fig 1A) and
the PtrCAld5H1 and PtrCAld5H2 knockdowns ( Fig 1B) we observed significant changes 496 in the PtrPAL, PtrHCT, PtrCCoAOMT2, PtrCAld5H, PtrC3H3, and Ptr4CL proteins. 497 At least one protein in each of those families was found to have glycosylation motifs [16] . 498 The PtrHCT proteins, particularly, had significant changes in their protein abundances, 499 which were not observed in their transcripts across multiple transgenic knockdowns 500 ( Fig 1A,B ,D,E, Fig S4A,B ), or where their transcripts were differentially expressed but 501 the proteins were not significantly different from wildtype (Fig 1C, Fig S2B) . Further, 502 there appear to be relationships among the PtrHCT, Ptr4CL, PtrCCoAOMT3, and the 503 PtrCAD1 proteins (Fig 1D,E, Fig S4A,B) , with reciprocal indirect influences between 504 the Ptr4CL and PtrCCoAOMT3 proteins, suggesting a potential feedback mechanism. 505 The sparse maximum likelihood estimator detected several connections among these 506 proteins, including positive influences from p4CL3, p4CL5, pCAD1 and pHCT1 on 507 pCCoAOMT3, from p4CL5, pCCoAOMT3, and pHCT1 on pCAD1, from the p4CLs 508 and pCCoAOMT3 on the pHCTs, and from pCCoAOMT3 and the pHCTs on the 509 p4CLs ( Fig 4A) . Further experiments are needed to identify the specific regulatory 510 mechanisms that are responsible for these cross-influences. 511 We used the connections identified by the sparse maximum likelihood estimator to 512 define our new transcript-protein model for monolignol biosynthesis. Using this model, 513 we emulated the 225 wildtype and transgenic knockdown experiments using only the 514 measured transcript abundances from the targeted monolignol genes as an input and 515 estimating the abundances of the other, untargeted, transcripts and proteins. We 516 compared these estimates to those found using the old model [4] , which assumes the Fig 7C-H) , and PtrCAld5H2 in the Ptr4CL3 and Ptr4CL5 knockdowns (Fig 8C-D) . 529 However, using only the targeted PtrCAD1 and PtrCAD2 or Ptr4CL3 and Ptr4CL5 530 transcripts respectively, our model was still able to estimate the decreases in both the 531 transcripts and proteins for all four of these genes. Additionally, our model was able to 532 capture several changes in protein abundances that the old model was not, including PtrHCT1 proteins in the PtrCCoAOMT3 transgenics. Our model includes relationships 538 from pCCoAOMT3 to p4CL3 and pHCT1. Despite this, our model does not capture the 539 size of the decrease in the abundances of these proteins. One explanation for why the 540 extent of these regulatory influences are not captured in our simulations could be due to 541 constraining the regulatory influences to additive linear relationships. Some of the 542 shortcomings of an additive linear model include not allowing for nonlinear relationships 543 and not being able to capture synergistic influence behaviors (i.e., when multiple 544 components are needed to see an effect).
545
The monolignol proteins are the driving forces in the biosynthesis pathway, so being 546 able to accurately understand and estimate how they change under different 547 combinations and degrees of targeted genetic modifications is important for the accuracy 548 of predictive models. Regulatory influences that occur after transcription appear in the 549 monolignol data of stem differentiated xylem tissue in P. trichocarpa, and we have 550 developed a computational model that incorporates influences on both the monolignol 551 transcripts and proteins. We have demonstrated specific examples where our model 552 produces better estimates of experimental monolignol gene proteins than the old model 553 when both models use only the targeted monolignol transcript abundances as input. In 554 several cases our model, using only the targeted transcript abundances, produced better 555 estimates than scenario 2 of the old model where all of the experimental transcript 556 abundances were used. By incorporating these indirect regulatory influences, we believe 557 our model has improved ability to explore the cascaded impact of genetic modifications 558 on resulting lignin and wood characteristics. Future work will evaluate how our model 559 performs on independent data, incorporate the model into the multi-scale model in [4] , 560 and use the multi-scale model to explore the possible changes in lignin and wood 561 characteristics under combinations of lignin gene modifications.
562
Methods
563
Monolignol transcript-protein model 564 The multi-scale lignin biosynthesis model presented in [4] spans multiple biological 565 layers from the genome to observed lignin and wood physical and chemical traits.
566
However, that model [4] makes the simplifying assumption that each monolignol gene's 567 protein abundance is dependent only on its transcript abundance. This does not reflect 568 any changes that are observed in the abundance of the non-targeted genes. Here, we 569 present a new model that incorporates the observed influences that estimate the 570 production of untargeted monoligninol transcripts and proteins. The code associated 571 with this model can be found at 572 https://github.ncsu.edu/mlmatth2/Monolignol-Cross-Regulation-Model.
573
Because we are interested in identifying regulatory influences at not only the 574 transcriptional level, but also the translational level, we combined the two datasets, 575 such that we are now looking at each of the 20 transcripts and 20 proteins as 40 total 576 variables in our model.
577
Model development 578 The goal of the model development is to find the underlying influences on each 579 monolignol gene product (its transcripts and proteins) when the expression of other 580 monoligninol genes are modified. We describe each transcript and protein as a linear 581 combination of the other transcripts and proteins as shown in Eq (1) .
Where y i is the abundance of the i th gene product, and we have M total gene 583 products ( M 2 transcripts and M 2 proteins). B ij is a constant term that reflects the 584 influence of gene product j on gene product i, µ i is a constant that represents the 585 portion of y i that is not described by the other lignin gene products, and is the error. 586 The influences described by B ij should be consistent across multiple experiments, so we 587 can describe Eq (1) over a collection of experiments as shown in Eq (2) .
Where y i ∈ N is the abundances of i th gene product over N experiments. We can 589 combine this into one model for all the transcripts and proteins as shown in Eq (3). 
592
B ∈ M ×M is the collection of influence terms B ij . Because each y i is a function of the 593 other gene products y j ∀j = i, the diagonal elements of B, B ii = 0 ∀i. Additionally, we 594 also enforce a constraint that a transcript cannot be influenced by its associated protein 595 (p i → t i ). µ ∈ M is a vector containing a constant term for each gene product, and 596 1 ∈ N is a vector of all ones. E = 1 2 · · · N represents the error where 597 j ∼ N (0, σ 2 I) and is considered independent and identically distributed. 598 We used a sparse maximum likelihood (SML) estimator [29] adjusted for our model 599 and data structure (S1 Text) to solve for B and µ. SML adds an 1 -norm regularization 600 term to the maximum likelihood, encouraging elements of B to be zero if they are not 601 sufficiently useful to describing Y. A coordinate-ascent algorithm is used, allowing us to 602 solve for the influences defined in B and µ on a row-by-row basis as described in Eq (2) . 603 This allows us to control which experiments are used to solve for the i th row of B and 604 µ, b T i and µ i respectively. This is important because we do not want to include the 605 experiments where component i was targeted. In those experiments, an outside 606 influence that is not included in the model is impacting its abundance. Only transcripts 607 were considered to be targets at this stage, as those are what is directly modified in the 608 knockdown experiments. See S1 Text for more details on the model development and 609 SML approach.
610
Estimating monolignol transcripts and proteins 611 We can use the influences B and µ solved for in the model development stage and 612 Eq (4) to estimate how knocking down a single or combination of monolignol genes 613 alters the abundances of the untargeted monolignol transcripts and proteins. 614 y pred = (I − K targ B) −1 (K targ µ + x targ ).
We set the abundance of our targeted components to the desired knocked down 615 amount using the vector x targ ∈ M , and remove the model influences that would alter 616 these set abundances using K targ ∈ M ×M . Where x targ = i∈targ x i e i and 617 K targ = I − i∈targ e i e T i . e i is the i th unit vector. This configuration allows us to set 618 the targeted monolignol gene components to a desired value while keeping the 619 relationships that influence the untargeted monolignol transcripts and proteins.
620
A drawback of using the additive linear model to describe both the monolignol 621 transcripts and proteins, is that a complete knockout of a targeted transcript may not 622 result in our model estimating its protein to be completely knocked out as well. This 623 presents an issue if the goal is to examine the impact of complete knockouts of targeted 624 monolignol genes. To get around this issue, we assume that the targeted change in a 625 transcript results in a proportional change to its protein abundance. For example, if we 626 want to see what happens when we knock transcript 1, t 1 down to 10% of its wildtype 627 abundance, then x T targ = 0.1 · t wt 1 0 · · · 0.1 · p wt 1 0 · · · 0 and 628 K targ = I − e 1 e T 1 − e 1+M/2 e T 1+M/2 .
629
Differential abundance analysis 630 We performed the differential abundance analysis for the monolignol gene transcripts [4] 631 using the R package DESeq2 [45] for each batch individually using the RNA-seq 632 libraries available under GEO accession number GSE78953. The proteomics data [4] 
